Federal Reserve Chair Jerome Powell has asked the U.S. central bank's inspector general to review the costs involved in the renovation of its historic headquarters in Washington, as Trump ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Inflammation and other complications with dental implants are common. Results from a double-blind randomized controlled trial in 34 patients with implants ...
BioGaia demonstrated a solid performance in Q4 2024, with sales growth across all major regions. The company's focus on ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOGB) A double-blind, randomised, placebo-controlled study in 45 women with pregnancy gingivitis showed that supplementation of L. reuteri ...
* Has signed an agreement with BioWellTech Co Ltd for the rights to sell BioGaia ProDentis in Hong Kong. Sign up here. * The launch is planned to take place during the third quarter of 2016. Source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results